# Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-and-efficacy-of-erenumab-for-preventive-treatment-of-chronic-migraine-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Stewart J. Tepper,Messoud Ashina,Uwe Reuter,Jan Lewis Brandes,David Doležil,Stephen D. Silberstein,Paul Winner,Dean Leonardi,Daniel D. Mikol,Robert Lenz |
| Citations | 740 |
| DOI | 10.1016/s1474-4422(17)30083-2 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2608751463 |
| PMID | 28460892 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Paul Winner](https://scholariq.org/researchers/paul-winner/)

## Paper primary topic

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)

## Paper topics

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)
- [Phosphodiesterase function and regulation](https://scholariq.org/topics/phosphodiesterase-function-and-regulation/)
- [Respiratory and Cough-Related Research](https://scholariq.org/topics/respiratory-and-cough-related-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.